DNA (deoxyribonucleic acid), the molecular "blueprint" carrying the genetic instructions that influence the growth, ...

A research group has developed SPACIER, an advanced polymer material design tool that integrates machine learning with ...

The way the body ages could be more resilient than previously thought, a new study suggests.

Jan. 27, 2025 — An international team of scientists has discovered a way to store and release volatile hydrogen using lignin-based jet fuel that could open new pathways for sustainable energy ...

Far from being uniform in structure and function ... Interferon-stimulated gene 15 (ISG15), a ubiquitin-like molecule with two ubiquitin fold repeats, contains the same C-terminal sequence ...

Rob Davis emphasized Merck's strong performance in 2024, driven by demand for KEYTRUDA, the launch of WINREVAIR, and robust growth in Animal Health. Davis highlighted challenges in GARDASIL sales in ...

Back to Healio The phase 3 HYPERION trial of Winrevair in adults with newly diagnosed pulmonary arterial hypertension functional class two or three is ending early due to robust positive evidence ...

This decision suggests that Winrevair has shown significant benefits for patients with pulmonary arterial hypertension, which was initially observed in the STELLAR trial. Graybosch believes that ...

Winrevair generated $200M Get the Real Story Behind Every Major Earnings Report Merck reported adjusted EPS of $1.72, up from $0.03 a year ago and beating the consensus of $1.62. Lower charges for ...